AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,925 | +9.9% | 10,502 | +25.7% | 0.00% | 0.0% |
| Q2 2023 | $236,585 | +23.3% | 8,354 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $191,891 | -18.2% | 8,354 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $234,580 | +23.5% | 8,354 | +24.1% | 0.00% | 0.0% |
| Q3 2022 | $190,000 | +27.5% | 6,731 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $149,000 | -24.0% | 6,731 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $196,000 | -11.3% | 6,731 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $221,000 | -28.9% | 6,731 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $311,000 | -16.2% | 6,731 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $371,000 | +6.6% | 6,731 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $348,000 | +3.9% | 6,731 | -13.0% | 0.00% | 0.0% |
| Q4 2020 | $335,000 | +23.6% | 7,738 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $271,000 | -34.5% | 7,738 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $414,000 | +116.8% | 7,738 | +44.0% | 0.00% | +100.0% |
| Q1 2020 | $191,000 | -12.8% | 5,373 | +17.4% | 0.00% | 0.0% |
| Q4 2019 | $219,000 | +84.0% | 4,577 | +24.8% | 0.00% | +100.0% |
| Q3 2019 | $119,000 | -35.0% | 3,666 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $183,000 | -6.2% | 3,666 | +27.0% | 0.00% | 0.0% |
| Q1 2019 | $195,000 | +22.6% | 2,887 | -16.5% | 0.00% | 0.0% |
| Q4 2018 | $159,000 | -31.8% | 3,457 | +14.2% | 0.00% | 0.0% |
| Q3 2018 | $233,000 | 0.0% | 3,027 | +9.3% | 0.00% | 0.0% |
| Q2 2018 | $233,000 | -4.5% | 2,769 | -7.2% | 0.00% | 0.0% |
| Q1 2018 | $244,000 | +63.8% | 2,985 | +14.8% | 0.00% | +100.0% |
| Q4 2017 | $149,000 | +21.1% | 2,600 | +41.5% | 0.00% | 0.0% |
| Q3 2017 | $123,000 | +29.5% | 1,838 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $95,000 | -1.0% | 1,838 | +12.2% | 0.00% | 0.0% |
| Q1 2017 | $96,000 | +41.2% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $68,000 | -21.8% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $87,000 | +40.3% | 1,638 | +9.9% | 0.00% | 0.0% |
| Q2 2016 | $62,000 | +226.3% | 1,491 | +210.6% | 0.00% | – |
| Q1 2016 | $19,000 | -38.7% | 480 | 0.0% | 0.00% | – |
| Q4 2015 | $31,000 | +93.8% | 480 | +115.2% | 0.00% | – |
| Q3 2015 | $16,000 | +77.8% | 223 | +182.3% | 0.00% | – |
| Q2 2015 | $9,000 | +28.6% | 79 | 0.0% | 0.00% | – |
| Q1 2015 | $7,000 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |